The Trump administration said Tuesday it will limit approval for seasonal COVID-19 shots to seniors and others at high risk ...

The US Food and Drug Administration has fully approved a new COVID vaccine option specifically targeting high-risk individuals, including seniors. The protein-based Nuvaxovid vaccine, produced by ...

The U.S. Food and Drug Administration on Tuesday said it plans to require new clinical trials for approval of annual COVID-19 ...

In the NEJM article, the FDA notes that covid booster uptake has been low in the US, with less than a quarter of people ...

About a fourth of younger men surveyed in the United States feel lonely, which is significantly higher than the national ...

A new COVID-19 vaccine has been approved, but it's not available to everyone. Aerial drone footage shows the humpback whale (Megaptera novaeangliae) missing its iconic lobed fluke, which is ...

The VRBPAC meeting comes the week after the World Health Organization (WHO) recommended that members consider using ...

Novavax's shot is now fully approved in the U.S. Since 2022, the vaccine has been used under an emergency use authorization. Health experts consider it a valuable alternative to messenger RNA shots ...

The new framework was well-received by biopharma analysts, who say it “largely formalizes” current COVID-19 vaccination ...